CanSino Biologics Inc.
Clinical trials sponsored by CanSino Biologics Inc., explained in plain language.
A vaccine company developing and manufacturing vaccines, including for COVID-19.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a Freeze-Dried vaccine shield all ages from hib? Results expected Oct 2026 (estimated)
- Could a Virus-Like particle vaccine outsmart polio? Results expected Oct 2026 (estimated)
- Tetanus immunity under the microscope: do antibodies hold up after 2.5 years? Results expected Nov 2026 (estimated)
- New 24-Strain pneumonia vaccine enters human trials Results expected Nov 2026 (estimated)
- New vaccine aims to shield infants from deadly pneumonia Results expected Feb 2027 (estimated) 🚀 Make-or-break
-
New 24-Strain pneumonia vaccine enters human trials
Vaccine Recruiting nowThis study tests a new vaccine (PCV24) designed to protect against 24 types of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. The trial includes 854 healthy people aged 2 months and older, split into two phases to check safety and immune respons…
Phase 1/2 • Sponsor: CanSino Biologics Inc. • Aim: Vaccine
Last updated Aug 07, 2026 00:00 UTC
-
One shot to rule them all? new combo vaccine trial for kids begins
Vaccine Recruiting nowThis early-stage trial is testing a new vaccine that combines protection against several serious childhood diseases: diphtheria, tetanus, whooping cough, meningitis, and Hib. The study involves 260 children aged 2 months to 6 years to check the vaccine's safety and immune respons…
Phase 1 • Sponsor: CanSino Biologics Inc. • Aim: Vaccine
Last updated Jun 27, 2026 08:07 UTC